Header cover image

Emirati (ADX) Pharma Industry Analysis

UpdatedApr 30, 2024
DataAggregated Company Financials
Companies1
  • 7D-2.0%
  • 3M-19.6%
  • 1Y-3.6%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 3.6%, driven by declines from every company within the industry. As for the longer term, the industry's performance has been flat for the past year.

Industry Valuation and Performance

Has the Emirati Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Apr 2024د.إ1.1bد.إ1.6b-د.إ103,600,000.00n/a-10.5x0.7x
Thu, 28 Mar 2024د.إ1.1bد.إ1.6b-د.إ103,600,000.00n/a-10.7x0.7x
Sat, 24 Feb 2024د.إ1.2bد.إ1.6b-د.إ103,100,000.00n/a-11.9x0.7x
Mon, 22 Jan 2024د.إ1.6bد.إ1.6b-د.إ127,700,000.00n/a-12.2x1x
Wed, 20 Dec 2023د.إ901.1mد.إ1.6b-د.إ127,700,000.00n/a-7.1x0.6x
Fri, 17 Nov 2023د.إ917.3mد.إ1.6b-د.إ127,700,000.00n/a-7.2x0.6x
Sun, 15 Oct 2023د.إ884.9mد.إ1.6b-د.إ84,700,000.00n/a-10.4x0.5x
Tue, 12 Sep 2023د.إ968.1mد.إ1.6b-د.إ84,700,000.00n/a-11.4x0.6x
Thu, 10 Aug 2023د.إ1.0bد.إ1.7b-د.إ38,400,000.00n/a-26.2x0.6x
Sat, 08 Jul 2023د.إ981.9mد.إ1.7b-د.إ38,400,000.00n/a-25.6x0.6x
Mon, 05 Jun 2023د.إ1.0bد.إ1.7b-د.إ38,400,000.00n/a-26.9x0.6x
Wed, 03 May 2023د.إ1.1bد.إ1.6b-د.إ33,900,000.00n/a-33.3x0.7x
Fri, 31 Mar 2023د.إ1.1bد.إ1.6b-د.إ33,900,000.00n/a-33.6x0.7x
Sun, 26 Feb 2023د.إ1.2bد.إ1.7b-د.إ28,400,000.00n/a-43.5x0.7x
Tue, 24 Jan 2023د.إ1.3bد.إ1.7b-د.إ28,400,000.00n/a-44.7x0.8x
Thu, 22 Dec 2022د.إ1.4bد.إ1.7b-د.إ28,400,000.00n/a-47.6x0.8x
Sat, 19 Nov 2022د.إ1.4bد.إ1.7b-د.إ28,400,000.00n/a-48x0.8x
Mon, 17 Oct 2022د.إ1.5bد.إ1.6bد.إ200.0k7588.2x7451.2x0.9x
Wed, 14 Sep 2022د.إ1.5bد.إ1.6bد.إ200.0k7588.2x7451.2x0.9x
Fri, 12 Aug 2022د.إ1.6bد.إ1.4bد.إ64.2m24.3x24.3x1.1x
Sun, 10 Jul 2022د.إ1.5bد.إ1.4bد.إ64.2m23.4x23.4x1.1x
Tue, 07 Jun 2022د.إ1.4bد.إ1.4bد.إ64.2m22.5x22.5x1x
Thu, 05 May 2022د.إ1.6bد.إ1.1bد.إ46.5m34.3x34.3x1.4x
Sat, 02 Apr 2022د.إ1.6bد.إ1.1bد.إ46.5m34.3x34.5x1.4x
Mon, 28 Feb 2022د.إ1.7bد.إ872.6m-د.إ145,500,000.00n/a-11.6x1.9x
Wed, 26 Jan 2022د.إ2.0bد.إ872.6m-د.إ145,500,000.00n/a-13.8x2.3x
Fri, 24 Dec 2021د.إ2.1bد.إ872.6m-د.إ145,500,000.00n/a-14.3x2.4x
Sun, 21 Nov 2021د.إ2.1bد.إ872.6m-د.إ145,500,000.00n/a-14.5x2.4x
Tue, 19 Oct 2021د.إ2.2bد.إ693.8m-د.إ180,900,000.00n/a-11.9x3.1x
Thu, 16 Sep 2021د.إ2.2bد.إ693.8m-د.إ180,900,000.00n/a-12x3.1x
Sat, 14 Aug 2021د.إ2.1bد.إ693.8m-د.إ180,900,000.00n/a-11.7x3x
Wed, 09 Jun 2021د.إ1.7bد.إ642.2m-د.إ245,600,000.00n/a-6.9x2.6x
Price to Earnings Ratio

-7.5x


Total Market Cap: د.إ1.8bTotal Earnings: -د.إ245,600,000.00Total Revenue: د.إ642.2mTotal Market Cap vs Earnings and Revenue0%0%0%
Emirati Pharma Industry Price to Earnings3Y Average 613.8x202220232024
Current Industry PE
    There is only one company in the Emirian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 37% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Emirati Pharma compare with similar industries?

AE Market-0.71%
Healthcare-0.90%
Pharma-1.98%
Pharma-1.98%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

JULPHAR

د.إ0.94

Gulf Pharmaceutical Industries P.S.C

7D

-2.0%

1Y

-3.6%